SPNT heads into tomorrow's Q2 earnings release riding a 7.4% weekly gain — but with options traders beginning to hedge at the highest put/call ratio in over a month.
The options signal is the most interesting development this week. Calls still dominate the flow, but the put/call ratio has climbed to 0.029 from near zero in mid-June, a level that, while modest in absolute terms, runs about one standard deviation above its 20-day average of 0.017. That's a meaningful shift for a stock where downside protection has barely registered all year. The 52-week high on the PCR is 0.312, so traders are nowhere near panicked — but the pattern of rising put demand into the print is worth noting.
The lending market tells a completely unencumbered story. Availability is extremely loose at 1,702%, meaning there are roughly 17 shares available to borrow for every one currently lent out. Borrowing costs are negligible at 0.55% and have barely moved in a month. Short interest is a real but modest 3.8% of free float — and that figure has been drifting slightly lower this week, down about 0.7%. What's more interesting is the 30-day picture: shorts have added roughly 35% more exposure since late June, building steadily from around 3.3 million shares to 4.5 million. That build happened as the stock rallied, suggesting a portion of those shorts are now underwater.
The Street angle is mixed but leans constructive, even if the analyst coverage here is thin and somewhat dated. Two of the three covering analysts carry buy-equivalent ratings, and the consensus price target of roughly $26.33 sits almost exactly where the stock is trading right now at $26.31 — meaning the sell-side has essentially caught up to the recent rally, leaving limited modelled upside from current levels. The most recent initiation on record came from B. Riley Securities in July 2025 with a $30 target, which at least suggests a bull case still exists above the current price. Valuation multiples have been quietly re-rating: the price-to-book has expanded about 9% in the past 30 days to 1.18x, and the PE now runs near 9.8x — still undemanding for an insurer with an EV/EBIT factor score in the 91st percentile of the ORTEX universe. The EPS surprise score ranks in the 79th percentile, a decent beat rate heading into tomorrow's print.
On ownership, the holder list is notable for its activist flavour. Third Point LLC — Dan Loeb's hedge fund — holds 6.2% of shares and has not reduced its position through the most recent filing period, while Donald Smith & Co. holds 8.1% and added roughly 2.1 million shares in Q1. Both are known value-oriented investors. BlackRock added 863,000 shares through June 30. The insider picture is less encouraging: the CEO, CFO, and several divisional heads all sold in late April at prices around $23.29, and the CFO made another small sale at $21.35 in late May. The insider net over the past 90 days actually shows a positive figure — $12.4 million net — but this appears to be driven by the scale of the April activity, much of which is likely tied to equity compensation plans rather than conviction buys.
SPNT has outperformed most of its reinsurance peers this week. EG and ACGL both gained around 5.7-5.9%, while GLRE added 7.2% — but SPNT's 7.4% advance puts it near the top of the group. Tomorrow's Q2 print is the next hard test: the two most recent earnings reactions both saw the stock slip in the days following the release, with a 5-day drift of around -2.3% to -4.8% in each case. The question is whether the current valuation re-rating and active institutional ownership provide enough of a floor if the print disappoints.
The setup heading into tomorrow is one of momentum meeting modest caution — the shorts who built positions through June have done so into a rising tape, the options market is edging toward defensive, and the analyst consensus has run out of headroom at current prices.
See the live data behind this article on ORTEX.
Open SPNT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
